Posted on 11/28/16
MWPH Appoints Jill Feinberg as VP of Development and External Affairs
Mt. Washington Pediatric Hospital (MWPH) announced the promotion of Jill Feinberg as Vice President for Development and
Posted on 11/28/16
Towne Park Selected as a Best Place to Work
ANNAPOLIS, Md.--(BUSINESS WIRE)--Towne Park, a national leader in hotel and healthcare services, announced today that it has received a 2016 CARE Award. The award recognizes companies . . .
Posted on 11/28/16
Doctors Regional Cancer Center’s Dr. Heather Lee Named Top Doctor
Dr. Heather Lee, a board-certified radiation oncologist on staff at Doctors Regional Cancer Center, was named among the 2016 Castle
Posted on 11/23/16
Immunomic Therapeutics Announces Expansion of IP Portfolio
ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc. (ITI), a privately-held, Maryland-based biotechnology company, today announced the issuance of a new United States Patent which extends ITI’s intellectual property . . .
Posted on 11/23/16
Health Facilities Association Of Maryland Appoints Tracy Immel To Policy And Government Relations Director
The Health Facilities Association of Maryland (HFAM) has promoted Tracy Immel to the director of policy and government relations. In this position, Immel will lead long-term . . .
Posted on 11/23/16
NKF-MD’s #GivingTuesday Campaign Nov. 29 To Support Low Income Patients with Chronic Kidney Disease
LUTHERVILLE, Md. - The National Kidney Foundation of Maryland (NKF-MD) has joined #GivingTuesday, a global day of giving that harnesses the collective power of individuals, communities . . .
Posted on 11/22/16
Trumpcare Could Be a Disaster for America's Healthcare System -- Here's Why
IMAGE SOURCE: GETTY IMAGES.Are the Affordable Care Act's days numbered? According to the campaign talk of President-elect Donald Trump, it's just a matter of time before . . .
Posted on 11/21/16
5 Most Expensive Medicare Drugs -- and Which Companies Are Getting Rich From Them
Medicare spends billions of dollars each year on prescription drugs. That's not surprising. What might be surprising, though, is how much the federal healthcare program spends . . .
Posted on 11/21/16
Synthetic Biologics Closes Stock Offering
Synthetic Biologics, Inc. (NYSE MKT: SYN), a late-stage clinical company developing therapeutics focused on the gut microbiome, today announced the closing of its previously announced underwritten . . .
Posted on 12/13/16
A Video Conversation with Kevin Keenahan, Co-founder and CEO of Tissue Analytics - Part IV
Brought to you by KatzAbosch CPAs
Posted on 12/8/16
A Video Conversation with Kevin Keenahan, Co-founder and CEO of Tissue Analytics - Part III
Brought to you by KatzAbosch CPAs
Posted on 11/28/16
A Video Conversation with Kevin Keenahan, Co-founder and CEO of Tissue Analytics - Part II
Brought to you by KatzAbosch CPAs
Posted on 11/17/16
A Video Conversation with Kevin Keenahan, Co-founder and CEO of Tissue Analytics - Part I
Brought to you by KatzAbosch CPAs
Posted on 11/17/16
New Behavioral Health Center Opens at Harbor Hospital in Cherry Hill
Baltimore residents suffering from behavioral health issues have a new facility reserved for them in Cherry Hill. Today, MedStar opened the doors to its new state-of-the-art . . .
Posted on 11/17/16
PharmAthene Receives Final Payment from SIGA of $83.9 Million
PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against anthrax, today received a final payment from SIGA Technologies, Inc. of $83.9 million which . . .
Posted on 11/17/16
Health Facilities Association of Maryland Presents Sister M. Karen McNally, RSM, with Lifetime Achievement Award
Health Facilities Association of Maryland (HFAM), a non-profit organization that represents and advocates for long-term and post-acute care providers, announced that Sister M. Karen McNally, RSM, . . .
Posted on 11/15/16
Synthetic Biologics Prices Stock Offering
Synthetic Biologics, Inc. (NYSE MKT: SYN), a late-stage clinical company developing therapeutics focused on the gut microbiome, today announced the pricing of an underwritten public offering . . .
Posted on 11/15/16
Integrated BioTherapeutics Announces Licensing Agreement with Emergent BioSolutions
Integrated BioTherapeutics (IBT) announced today that it has entered into an exclusive worldwide license agreement with Emergent BioSolutions Inc. (NYSE: EBS) whereby Emergent will gain exclusive . . .
Posted on 11/15/16
UM Upper Chesapeake Cardiology Selected to Participate in National Initiative to Prevent Heart Attacks, Strokes
University of Maryland Upper Chesapeake Cardiology has been selected by the Centers for Medicare & Medicaid Services (CMS) as one of 516 awardees in 47 states, . . .
Posted on 11/15/16
Synthetic Biologics Announces Commencement of Public Offering of Common Stock
Synthetic Biologics, Inc. (NYSE MKT: SYN), a late-stage clinical company developing therapeutics focused on the gut microbiome, today announced that it has commenced an underwritten public . . .
Posted on 11/14/16
Omega Healthcare Investors: Just Fine Even If Rates Rise
I think we are already feeling the effects of a Donald Trump presidency in the bond market. The long-term US Treasury ETF (NYSEARCA:IEF) tells the story . . .
Posted on 11/14/16
CASI Pharmaceuticals Reports Third Quarter 2016 Financial Results
CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company dedicated to innovative therapeutics addressing cancer and other unmet medical needs, today reported financial results for the three . . .
Posted on 11/14/16
Angelini and APR Applied Pharma Research Strengthen Their Partnership in Wound Care
GAITHERSBURG, Md.--(BUSINESS WIRE)--The new Nexodyn® AOS Wound Care Solution, cleared for sale by the FDA, is now starting to be available in the USA, promoted and . . .
Posted on 11/11/16
Why Novavax, Inc. Is Tanking Today
IMAGE SOURCE: GETTY IMAGES.What happenedShares of Novavax (NASDAQ:NVAX), a clinical-stage vaccine maker, fell by more than 17% in pre-marketing trading on Thursday. The biotech's latest move . . .
Posted on 11/11/16
Emergent Biosolutions Inc Slimmed Down, Waiting on Contract
IMAGE SOURCE: GETTY IMAGES.Emergent BioSolutions (NYSE:EBS) reported earnings on Monday, but investors are still waiting for the big news from the biodefense specialist: terms of the . . .
Baltimore
